US FDA: Draft Labeling is enough to get ANDAs Approval
The US regulatory authority FDA recently stated via guidance it will provide green light to Abbreviated New Drug Applications (ANDAs)
Read moreThe US regulatory authority FDA recently stated via guidance it will provide green light to Abbreviated New Drug Applications (ANDAs)
Read more